Eris Lifesciences

Market Cap

17,368.05 Cr

EPS

28.82

PE Ratio

52.96

Dividend Yield

0.00 %

Industry

Healthcare

52 Week High

1,593.90

52 Week low

809.15

PB Ratio

6.29

Debt to Equity

0.76

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from8 analysts

Analysts have suggested that investors can buy this stock

Buy87.50 %

87.50 %

Hold12.50 %

12.50 %

Sell0.0 %

0.0 %

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,669.30	4,00,520.99	34.13	49,887.20	12.06	9,648	13.77	37.74
Divis Laboratories	5,978.30	1,58,705.08	76.14	8,184.00	0.89	1,600	64.53	51.57
Cipla	1,479.70	1,19,502.65	23.70	26,520.70	14.17	4,155	47.38	51.15
Torrent Pharmaceuticals	3,095.95	1,04,781.02	56.64	10,785.70	11.59	1,656	13.54	45.77
Dr Reddys Laboratories	1,170.95	97,705.34	18.09	28,905.40	12.36	5,578	1.69	30.83
Mankind Pharma	2,348.45	96,889.27	47.77	10,615.60	19.57	1,942	-16.38	39.42
Zydus Life Science	899.65	90,525.84	19.78	19,831.50	13.82	3,831	29.92	36.77
Lupin	1,977.50	90,213.07	31.46	20,141.50	19.94	1,936	38.82	38.83
Aurobindo Pharma	1,121.25	65,122.38	18.72	29,559.20	17.55	3,169	-10.04	42.81
Abbott	29,429.65	62,535.95	47.37	6,097.20	10.80	1,201	16.01	61.56

Growth Rate

Revenue Growth

19.85 %

Net Income Growth

6.12 %

Cash Flow Change

66.59 %

ROE

-26.88 %

ROCE

-14.45 %

EBITDA Margin (Avg.)

6.41 %

Quarterly Financial Results

Quarterly Financials	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	188	208	190	189	192	237	213	215	251	267	259	223	275	286	270	243	289	327	308	277	350	360	333	309	395	461	420	398	461	504	488	562	717	744	726
Expenses	109	125	112	135	114	152	128	141	162	164	159	153	170	175	190	171	189	205	203	184	223	220	210	209	269	309	286	284	297	324	311	403	470	477	477
EBITDA	79	83	78	54	78	86	85	75	88	103	100	70	105	111	81	72	100	122	105	93	127	141	123	100	125	151	134	114	164	180	177	160	248	267	249
Operating Profit %	40 %	37 %	39 %	27 %	39 %	34 %	38 %	32 %	34 %	37 %	36 %	28 %	38 %	38 %	28 %	30 %	34 %	37 %	33 %	33 %	35 %	38 %	36 %	31 %	31 %	32 %	32 %	28 %	35 %	35 %	36 %	26 %	34 %	35 %	34 %
Depreciation	5	5	6	7	5	5	7	9	7	8	10	11	12	12	13	14	10	11	11	12	15	15	17	18	23	29	30	35	41	42	46	54	76	81	81
Interest	0	1	0	0	0	0	3	8	7	6	5	4	1	1	0	0	0	0	0	1	1	1	1	1	7	7	3	9	17	16	18	33	60	60	57
Profit Before Tax	73	78	72	48	74	99	77	62	78	92	89	58	95	103	72	62	95	116	99	85	117	131	109	85	101	121	107	76	113	126	116	77	115	129	116
Tax	11	8	4	1	3	6	3	6	6	7	9	4	11	10	9	5	6	8	9	17	10	12	8	5	8	2	6	14	19	4	14	-3	26	33	29
Net Profit	63	69	68	47	71	93	75	56	72	86	80	54	84	93	64	56	89	108	90	68	107	118	101	80	93	119	100	62	94	122	102	80	89	96	87
EPS in ₹	45.64	5.02	4.95	3.43	5.15	6.75	5.43	4.06	5.18	6.20	5.83	3.93	6.11	6.74	4.62	4.13	6.56	7.93	6.64	5.03	7.86	8.71	7.41	5.91	6.96	8.84	7.49	4.81	6.97	9.08	7.55	5.22	6.11	6.73	6.15

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	398	727	1,460	1,554	1,552	1,835	2,272	3,667	7,049
Fixed Assets	65	232	771	761	875	854	918	2,568	4,328
Current Assets	237	216	299	582	480	467	627	765	2,302
Capital Work in Progress	0	0	0	3	4	2	27	22	20
Investments	144	303	365	356	78	294	520	37	16
Other Assets	190	192	324	435	595	685	807	1,041	2,686
Total Liabilities	398	727	1,460	1,554	1,552	1,835	2,272	3,667	7,049
Current Liabilities	71	76	226	306	165	167	200	443	2,532
Non Current Liabilities	25	60	349	79	91	91	164	1,003	1,295
Total Equity	302	591	886	1,169	1,296	1,576	1,908	2,221	3,222
Reserve & Surplus	302	553	848	1,137	1,283	1,563	1,894	2,182	2,573
Share Capital	0	14	14	14	14	14	14	14	14

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-2	4	-8	8	-3	60	-30	14	5	38
Investing Activities	-92	-44	-185	-590	-5	123	-323	-320	-975	-1,828
Operating Activities	90	132	200	235	223	271	375	378	292	486
Financing Activities	1	-84	-24	363	-221	-335	-82	-45	688	1,380

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Jan 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	55.55 %	54.13 %	52.69 %	52.68 %	52.66 %	52.66 %	52.30 %	52.29 %	52.70 %	52.86 %	52.86 %	54.91 %	54.90 %	54.90 %	54.88 %	54.87 %	54.86 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	13.20 %	0.00 %	14.27 %	14.59 %	8.01 %	8.35 %
DIIs	10.52 %	9.25 %	9.66 %	9.57 %	9.99 %	10.11 %	10.36 %	10.38 %	9.94 %	10.02 %	10.28 %	14.53 %	13.86 %	15.63 %	16.23 %	18.64 %	18.06 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	22.42 %	23.28 %	23.23 %	23.29 %	23.19 %	23.14 %	21.34 %	21.27 %	21.45 %	21.66 %	22.07 %	15.47 %	15.67 %	14.24 %	13.53 %	10.51 %	9.29 %
Others	11.51 %	13.34 %	14.42 %	14.46 %	14.16 %	14.09 %	16.01 %	16.07 %	15.90 %	15.46 %	14.79 %	1.90 %	15.57 %	0.95 %	0.77 %	7.96 %	9.43 %
No of Share Holders	29,195	41,470	46,477	49,833	54,223	57,061	51,639	48,055	46,746	45,931	44,169	42,245	46,496	51,753	44,176	46,346	53,314